1-2 of 2
Jose D. Gonzalez-San Miguel, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.

Jose Cervera, MD, Guillermo Martin, MD, Jesus M. Hernandez, MD, Edo Vellenga, MD, Maria J. Calasanz, MD, Jose A. Martinez-Climent, MD, Elisa Luño, MD, Maria T. Ferro, MD, Consuelo Rayon, MD, Marcos Gonzalez, MD, Mar Tormo, MD, Concha Rivas, MD, Elena Amutio, MD, Javier de la Serna, MD, Jose D. Gonzalez-San Miguel, MD, Juan Bergua, MD, Angel Leon, MD, Joaquin Diaz-Mediavilla, MD, Jose Garcia-Laraña, MD, Jordi Esteve, MD, Miguel A. Sanz, on behalf of the PETHEMA Cooperative Group
Journal: Blood
Blood (2004) 104 (11): 2019.
https://doi.org/10.1182/blood.V104.11.2019.2019
Published: 2004
Journal Articles

Microgranular Variant (M3V) of Acute Promyelocytic Leukemia (APL) Does Not Have a Worse Prognosis than Classical APL in the Atra Era: A Report of 153 Patients Treated on Intergroup 0129 and Pethema LPA96 and LPA99.

Martin S. Tallman, MD, Haesook T. Kim, PhD, Charles A. Schiffer, MD, Frederick R. Appelbaum, MD, James H. Feusner, MD, Angela K. Ogden, MD, Lois Shepherd, MD, Cheryl L. Willman, MD, Clara D. Bloomfield, MD, Jacob M. Rowe, MD, Richard A. Larson, MD, Peter H. Wiernik, MD, Guillermo Martin, MD, Chelo Rayon, MD, Javier de la Serna, MD, Concha Rivas, MD, Jose D. Gonzalez-San Miguel, MD, Guillermo Deben, MD, Miguel A. Sanz, MD
Journal: Blood
Blood (2004) 104 (11): 394.
https://doi.org/10.1182/blood.V104.11.394.394
Published: 2004